期刊文献+

湖州市甲3型流感病毒烷胺类药物耐药性分析 被引量:7

Adamantane resistance among influenza H3 subtype virus isolates from the mainland of Huzhou
原文传递
导出
摘要 目的:分析湖州市2009年-2012年流感流行期甲3型流感病毒流行株对金刚烷胺的耐药情况,为流感的临床治疗用药提供参考。方法:选取湖州市流感监测网络和流感暴发疫情中所分离的48株甲3型流感病毒株,提取病毒核酸,采用RT-PCR扩增病毒M2基因片段,纯化后进行核苷酸序列测定,用生物信息软件分析与耐药有关的氨基酸位点。结果:48株甲3型流感病毒分离株中,43株M2蛋白跨膜区耐药位点的氨基酸被置换,对金刚烷胺耐药率为89.58%。2009年-2012年4个流行期耐药率分别为85.71%、78.57%、94.12%和100%。变异主要发生在M2蛋白跨膜区第31位氨基酸,42株发生了S31N置换,占87.5%,其次是在第27位,有3株发生了V27A置换,占6.25%。结论:人群甲3型流感对金刚烷胺类药物耐药率较高,应加强耐药性监测,提醒卫生部门应对流感大流行谨慎使用此类药物。 Objective:To analyze the resistance of influenza H3 subtype isolates to amantadine in Huzhou during 2009-2012 and to provide a reference for the clinical use of amantadine.Methods:Forty-eight strains of influenza H3 subtype viral strains were randomly selected from influenza surveillance network and outbreaks in Huzhou,viral RNA was extracted,and M2 gene segments were amplified by reverse transcription polymerase chain reaction(RT-PCR).PCR products were purified and sequenced and the positions of amino acids providing resistance to amantadine were analyzed using biometric software.Results: Of the 48 strains of influenza H3 subtype virus,forty-three strains had amino acid changes at the transmembrane domain of the M2 protein;the resistance rate to amantadine was 89.58%.During the influenza season from 2009 to 2012,the resistance rates of influenza H3 subtype virus to adamantane were 85.71%,78.57%,94.12% and 100%.Of the 43 amantadine resistant strains,forty-two(87.5%) strains had amino acid changes at site S31N and three strains(6.25%)had changes at V27A.Conclusion: The rate of resistance to amantadine is high among the epidemic strains of influenza H3 suptype virus in population of Huzhou,so the hygiene department should strengthen drug-resistance monitoring for clinical rational use in influenza epidemic.
出处 《中国卫生检验杂志》 北大核心 2013年第4期1005-1007,共3页 Chinese Journal of Health Laboratory Technology
关键词 耐药性 流感病毒 M2离子通道 金刚烷胺 Drug resistance Influenza virus M2 ion channel Amantadine
  • 相关文献

参考文献10

  • 1Belshe RB, Smith MH, Hall CR, et al. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection[ J]. J Virol, 1988, 62(5) : 1508 -1512.
  • 2Hay A J, Zambon MC, Wolstenholme A J, et al. Molecular basis of re- sistance of influenza A viruses to amantadine[ J]. J Ant imicrob Che- mother, 1986, 18 (Suppl B): S19-$29.
  • 3苏文哲,柯昌文.流行性感冒病毒的耐药性相关研究进展[J].中国病毒病杂志,2011,1(3):171-176. 被引量:17
  • 4Astrahan P, Kass I, Cooper MA, et al. A novel method of resistance for influenza against a channel - blocking ant iviral drug[ J ]. Proteins, 2004, 55(2) : 251 -257.
  • 5Boivin G, Goyet te N, Bernat chez H. Prolonged excretion of amanta- dine resistant influenza A virus quasi species after cessation of antiviral therapy in an innnunocompromised patient[ J]. Clin Infect Dis, 2002, 34(5) : 23 -25.
  • 6Choi WY,Kim S,Lee N,et al. Amantadine -resistant influenza a viru- ses isolated in south Korea from 2003 to 2009 [ J]. Antiviral Res ,2009, 84(2) : 199 -202.
  • 7Centers for Disease Control and Prevention (CDC), High levels of amantane resistance among influenza A ( H3N2 ) viruses and interim guidelines for use of antiviral agents - United States, 2005 - 06 influ- enza season [J]. MM WR Morb Mortal Wkly Rep, 2006, 55 (2) : 44 -46.
  • 8蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 9杨红茹,齐顺祥,刘艳芳,刘兰芬,邸科前.人群甲型流感病毒M2蛋白变异与金刚烷胺耐药性分析[J].中国现代医学杂志,2008,18(23):3468-3471. 被引量:6
  • 10Ilyushina NA, Govorkova EA, Webster RG. Detection of amantadine - resistant variants among avian influenza viruses isolated in North A- merica and Asia[ J]. Virology, 2005, 341 (1) :102 -106.

二级参考文献56

  • 1奥野良信,万献尧,毕丽岩.金刚烷胺[J].日本医学介绍,2004,25(7):307-309. 被引量:20
  • 2蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 3Reuman PD,Bernstein DI,Keefer MC,et al.Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.Antiviral Res,1989,11:27-40.
  • 4Belshe RB,Burk B,Newman F,et al.Resistance of influenza A virus to amantadine and rimantadine:results of one decade of surveillance.J Infect Dis,1989,159:430-435.
  • 5Belshe RB,Smith MH,Hall CB,et al.Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.J Virol,1988,62:1508-1512.
  • 6Saiki RK,Gelfand DH,Stoffel S,et al.Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.Science,1988,239:487-491.
  • 7Bright RA,Medina MJ,Xu X,et al.Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005:a canse for concern.Lancet,2005,366:1175-1181.
  • 8Hay A J,Zambon MC,Wolstenholme A J,et al.Molecular basis of resistance of influenza A viruses to amantadine.J Antimicrob Chemother,1986,18 (Suppl B):S19-29.
  • 9Suzuki H,Saito R,Masuda H,et al.Emergence of amantadine-resistant influenza A viruses:epidemiological study.J Infect Chemother,2003,9:195-200.
  • 10Ziegler T,Hemphill ML,Ziegler ML,et al.Low incidence of rimantadine resistance in field isolates of influenza A viruses.J Infect Dis,1999,180:935-939.

共引文献44

同被引文献70

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部